4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,088.00p
   
  • Change Today:
      18.00p
  • 52 Week High: 1,088.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 0
  • Market Cap: £139.32m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,252,453 £13,626,689
Joseph Manuel Fernández 448,244 £4,876,895
David John Roth 316,000 £3,438,080
Maria Del Pilar de la Huerta 6,667 £72,537
Hansjörg Plaggemars 6,667 £72,537
Timothy Paul McCarthy 2,388 £25,981

Major Shareholders

Notifier** Holding Value*
DELPHI Unternehmensberatung AG 6,604,357 £71,855,404
Wilhelm K. T. Zours 6,604,357 £71,855,404
Deutsche Balaton AG 5,965,921 £64,909,220
4bb AG 3,665,242 £39,877,833
2invest AG 3,665,242 £39,877,833
Sparta AG 1,351,718 £14,706,692

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,088.00p
Change Today 18.00p
% Change 1.68 %
52 Week High 1,088.00
52 Week Low 500.00
Volume 0
Shares Issued 12.81m
Market Cap £139.32m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.05% below the market average70.05% below the market average70.05% below the market average70.05% below the market average70.05% below the market average
32.08% below the sector average32.08% below the sector average32.08% below the sector average32.08% below the sector average32.08% below the sector average
Price Trend
97.48% above the market average97.48% above the market average97.48% above the market average97.48% above the market average97.48% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
34.89% below the market average34.89% below the market average34.89% below the market average34.89% below the market average34.89% below the market average
51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average

4basebio Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page